How do I transfer my Mantle Cell Lymphoma care to another hospital

Mantle_cell_lymphomaMay 22, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Transferring Your Mantle Cell Lymphoma Care to Another Hospital

I appreciate this practical question. While transferring care is an important logistical step, let me help you understand both the process and what to consider for your specific situation with mantle cell lymphoma.

Key Steps for Transferring Care

1. Notify Your Current Care Team

  • Inform your oncologist and medical team that you're planning to transfer
  • Request they prepare your complete [ID removed] (this is your right under HIPAA)
  • Ask for a summary letter from your current oncologist explaining your diagnosis, treatments received, and current status

**2. Gather Your [ID removed] You'll want to collect:

  • Pathology reports (showing your mantle cell lymphoma diagnosis)
  • Imaging studies (CT scans, PET scans) - ask for both the images AND the reports
  • Laboratory results and blood work
  • Treatment records (what chemotherapy or targeted therapies you've received)
  • Genetic/molecular testing results (important for mantle cell lymphoma, as certain mutations affect treatment decisions)
  • Any bone marrow biopsy results

3. Select Your New Hospital

  • Look for centers with lymphoma expertise, ideally with specialists experienced in mantle cell lymphoma
  • Consider whether they follow current NCCN Guidelines for Non-Hodgkin Lymphomas (which cover mantle cell lymphoma treatment)
  • Ask about their experience with mantle cell lymphoma specifically

4. Contact the New Hospital

  • Call the oncology department and ask to schedule a consultation
  • Tell them you're transferring care and have records to provide
  • Ask what additional testing or evaluation they may need

Important Considerations for Mantle Cell Lymphoma Specifically

According to NCCN Guidelines, mantle cell lymphoma treatment decisions depend heavily on:

  • Your disease stage (how advanced it is)
  • Prognostic factors (genetic markers that predict how aggressive your lymphoma is)
  • Prior treatments you've received and how your lymphoma responded
  • Your overall health status

Your new team will want to review all of this to determine the best next steps for YOUR specific situation.

Questions to Ask Your New Care Team

  1. "Have you reviewed my complete pathology report and genetic testing results?" - These are critical for mantle cell lymphoma
  2. "Based on my disease stage and prior treatments, what are your treatment recommendations?"
  3. "Do you follow the current NCCN Guidelines for mantle cell lymphoma?"
  4. "Will you need any additional testing before we proceed with a treatment plan?"
  5. "How will you coordinate with my previous oncologist if needed?"
  6. "What is your experience treating mantle cell lymphoma specifically?"

Red Flags to Watch For

  • A new team that doesn't want to review your complete records
  • Recommendations that seem very different from your previous team without clear explanation
  • Inability to access your imaging studies (ask for them on CD or through secure transfer)

Getting Your Records

As mentioned in patient advocacy resources, you have the right to your health data. If your current hospital is slow to provide records, you can:

  • Request them in writing
  • Ask specifically for "underlying data" including images, not just summary reports
  • Follow up if you don't receive them within the timeframe required by law (typically 30 days)

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: